Yuan Hong, Jiang Sai-Ping, Du Yong-Zhong, Miao Jing, Zhang Xing-Guo, Hu Fu-Qiang
College of Pharmaceutical Science, Zhejiang University, Hangzhou, PR China.
Colloids Surf B Biointerfaces. 2009 May 1;70(2):248-53. doi: 10.1016/j.colsurfb.2008.12.031. Epub 2008 Dec 31.
In order to introduce hydrophilic peptide drugs into solid lipid nanoparticles (SLN), a technique of combining hydrophobic ion pairing (HIP) and non-aqueous oil-in-oil (O/O) emulsion-evaporation was developed. Leuprolide (LR) was selected as the model drug, while sodium stearate (SA-Na) was used as the negative charged ion pairing material. The formation of leuprolide-sodium stearate (LR-SA-Na) complex was confirmed by differential scanning calorimetry (DSC). It was observed that when the molar ratio of SA-Na/LR reached 2/1, ca 88.5% LR was incorporated into the hydrophobic ion complexes with SA-Na. Compared with the conventional method of solvent diffusion in an aqueous system, the efficiency of LR drug entrapment with SLN increased from 28.0% to 74.6% by the combined technique of HIP and O/O emulsion-evaporation. In vitro drug release tests revealed that employing technique of HIP obviously reduced the burst release and slowed down the rate of drug release. At meanwhile, applying the method of non-aqueous O/O emulsion-evaporation, the longer time of drug release but relatively higher drug burst release ratio was observed in comparison with those by the solvent diffusion method in an aqueous system. The drug entrapment and release behaviors of LR-SA-Na SLN prepared by the O/O emulsion-evaporation method suggested that it could potentially be exploited as an oral delivery system for leuprolide.
为了将亲水性肽类药物引入固体脂质纳米粒(SLN),开发了一种疏水离子对(HIP)与非水油包油(O/O)乳液蒸发相结合的技术。选择亮丙瑞林(LR)作为模型药物,同时使用硬脂酸钠(SA-Na)作为带负电荷的离子对材料。通过差示扫描量热法(DSC)证实了亮丙瑞林-硬脂酸钠(LR-SA-Na)复合物的形成。观察到当SA-Na/LR的摩尔比达到2/1时,约88.5%的LR与SA-Na形成疏水离子复合物。与传统的水相体系中溶剂扩散方法相比,通过HIP与O/O乳液蒸发相结合的技术,SLN对LR药物的包封率从28.0%提高到了74.6%。体外药物释放试验表明,采用HIP技术明显降低了突释现象并减缓了药物释放速率。同时,应用非水O/O乳液蒸发方法时,与水相体系中溶剂扩散方法相比,观察到药物释放时间更长但突释率相对较高。通过O/O乳液蒸发法制备的LR-SA-Na SLN的药物包封和释放行为表明,它有可能被开发为亮丙瑞林的口服给药系统。